Skip to content

Article: A New Bioluminescent Probe to Monitor Mitochondrial Health Over Time: Preclinical Findings

A New Bioluminescent Probe to Monitor Mitochondrial Health Over Time: Preclinical Findings


Synopsis

Mitochondrial membrane potential (ΔΨm) is a key indicator of mitochondrial health and is involved in diseases like diabetes, cancer, Alzheimer’s, and Parkinson’s. This study introduces a new bioluminescent probe called mitochondria-activatable luciferin (MAL) that detects ΔΨm and, to some extent, plasma membrane potential (ΔΨp). MAL allows non-invasive, real-time monitoring of mitochondrial function both in lab cultures and living animals. Using MAL, researchers observed that aging reduces ΔΨm in mice, but treatment with nicotinamide riboside (NR) reverses this decline. The probe was also used to study brown fat activation and mitochondrial changes in cancer models. This tool offers new ways to understand mitochondrial function and develop treatments for various diseases.

Journal

Nature Chemical Biology

Read more

Preclinical

Nicotinamide Riboside Protects Against Light-Induced Retinal Degeneration: Preclinical Findings

SynopsisRetinal diseases cause a decline in nicotinamide adenine dinucleotide (NAD+), a vital coenzyme for cellular energy and biosynthesis, which may contribute to retinal damage. This study teste...

Read more
Cardiovascular Disease

Nicotinamide Riboside Supplementation Reduces Inflammation in Heart Failure Patients: Clinical Findings

Objectives To investigate the mechanistic link between mitochondrial dysfunction and inflammatory activation in peripheral blood mononuclear cells (PBMCs), and the potential anti-inflammatory effe...

Read more